BNP Paribas Financial Markets’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $210 | Sell |
|
|||||
|
2022
Q4 | $684 | Buy |
|
|||||
|
2022
Q3 | $252 | Sell |
|
|||||
|
2022
Q2 | $8.41K | Sell |
|
|||||
|
2022
Q1 | $261K | Sell |
|
|||||
|
2021
Q4 | $615K | Buy |
|
|||||
|
2021
Q3 | $66.6K | Buy |
|
|||||
|
2021
Q2 | $56.7K | Sell |
|
|||||
|
2021
Q1 | $514K | Buy |
|
|||||
|
2020
Q4 | $111K | Sell |
|
|||||
|
2020
Q3 | $122K | Buy |
|
|||||
|
2020
Q2 | $10K | Sell |
|
|||||
|
2020
Q1 | $28K | Buy |
|
|||||
|
2019
Q4 | $38.7K | Buy |
|
|||||
|
2019
Q3 | $20.2K | Buy |
|
|||||
|
2019
Q2 | $1.12K | Buy |
|